Send a text

Send a text

About Dr. Monica Jong

Dr. Monica Jong is the Global Director of Professional Education, Myopia at Johnson
& Johnson Vision where she leads practitioner education initiatives around the world to support evidence-based myopia management.
She was the former Executive Director of the International Myopia Institute, an organization she helped co-found. In this role Monica led the development of white papers and key initiatives to bring consensus to the field of myopia management by bringing together leading researchers, clinicians, educators, policy-makers and public health experts. Today these key white papers are utilized by peak health bodies and professional eye care associations worldwide.
Monica has published numerous peer reviewed articles in high impact journals in the areas of epidemiology, high myopia and clinical trials. She co-created the first global online education program in myopia at the Brien Holden Vision Institute. She was also the scientific secretary of the WHO meeting on myopia in 2015 and co-authored the WHO report on the Impact of Myopia and High Myopia. Monica was the former secretary of the Refractive Error Working group of the International Agency for Prevention of Blindness (IAPB) and contributed to position papers and advocacy initiatives in refractive error.
Monica has practiced optometry in private and corporate, rural and urban settings as well as public health. She is passionate about research and education and continues to mentor graduate students from developing and developed countries. Monica has presented at more than 400 global scientific and practitioner meetings. Monica like to keep physically and mentally fit byalso practicing Muay Thai, the art of eight limbs while spending time with her two children.

Send a text

About Azinda Morrow

Dr. Azinda Morrow is currently an Associate Optometrist at Silicon Valley Eyecare Optometry & Contact Lenses in Santa Clara, CA. She earned her Doctor of Optometry degree from SUNY College of Optometry in 2017 and completed her residency in Cornea and Contact Lenses at the Illinois College of Optometry in Chicago, IL in 2018. After completion of her residency, she was an Assistant Clinical Professor at the SUNY College of Optometry / University Eye Center and responsible for clinical supervision of students and residents in both the Cornea / Contact Lens and Myopia Management clinics. In addition, she taught in pre-clinical laboratories and was involved in clinical research. Now in private practice, Dr. Morrow continues to provide full-scope care to patients of all ages, as well as continuing her passion of caring for patients with specialty contact lens and myopia management needs. Dr. Morrow is also a fellow of the American Academy of Optometry, and a member of the American Optometric Association.

---

Thanks to TEEM for their support of this episode. If you're considering or have ever considered getting a virtual team member for your practice check out hiredteem.com, mention The Myopia Podcast when signing up for a $250 dollar discount off of your first month's teem member.

https://hireteem.com/myopia-podcast/

Send a text

About Dr. Rishi P. Singh MD,

Dr. Rishi P. Singh MD is a staff surgeon, vice president, and chief medical officer at the
Cleveland Clinic Martin Health and Professor of Ophthalmology at the Lerner College of Medicine in Cleveland Ohio. He received his bachelors and medical degrees from Boston University and completed his residency at the Massachusetts Eye and Infirmary Harvard Combined Program in Boston, Massachusetts. Dr. Singh then completed a medical and surgical fellowship at the Cole Eye Institute in Cleveland, Ohio.

He specializes in the treatment of medical and surgical retinal disease such as diabetic
retinopathy, retinal detachment, and age-related macular degeneration. Dr. Singh has
authored more than 250 peer reviewed publications, books, and book chapters and serves as the principal investigator of numerous national clinical trials advancing the treatment of retinal disease. Dr. Singh is the former president on the Retina World Congress and is on the board of the American Society of Retina Specialists.

Dr. Singh has been honored with several research recognitions such as the Alpha Omega Alpha Research Award and American Society of Retina Specialists Senior Honor Award.

Send a text

About Dr. Sherman Tung,

Dr. Sherman Tung, OD FAAO FIAOMC IACMM graduated from Illinois College of Optometry. As a 4th Year ICO externship preceptor, he is dedicated to mentoring future optometrists. A former president of BC Doctors of Optometry and recipient of the 2019 Optometrist of the Year award, Dr. Tung is celebrated for his contributions to advancing optometric standards. In addition to his role as co-chair for the accreditation team at the AAOMC (American Academy of Orthokeratology and Myopia Control), he owns and operates his private practice, Eyelab, Doctors of Optometry, in Vancouver, BC, Canada, where he continues to provide exceptional eye care services to the community.
IG: @helloeyelab

Send a text

About Dr. Justin Kwan

Dr. Justin Kwan is a 2009 graduate of Berkeley Optometry and went on to do a contact lens and dry eye residency at SCCO. He taught and saw patients there for eight years before moving to Chicago in 2018, joining a private practice. In April 2020, he transitioned to CooperVision full time, dedicated to myopia management. He has given over 100 hours of continuing education. Dr. Kwan is the current president of the Chicago North Side Optometric Society, past Editor in Chief of Clinical & Refractive Optometry, past chair of the Fellows Doing Research SIG of the Academy, and a member of the Intrepid Eye Society.

Send a text

Send a text

I want to give a special thank you to Syndexis for being a sponsor of The Myopia Podcast. If you're not aware Syndexis is a biopharmaceutical company that was founded in 2014, they're based in Del Mar California.
Their mission is to develop a proprietary stable accurate effective
safe topical eye drop to treat the progression of myopia in children
and to minimize the risk of co-morbidities later in life. They're on the cusp of a new treatment paradigm to fight myopia progression in children, they're in the late stage of their pivotal phase 3 trial for their investigation medication SYD1 01.

The Myopia Podcast and myself are rooting for them and are watching Syndexis closely.
Stay tuned!

Follow

Apple Podcasts
Spotify
Overcast
RSS FeedSee All